|
21 Feb 2007 |
New River Pharmaceuticals to be Acquired by Shire plc for $64 per Share
|
|
21 Feb 2007 |
Cyberkinetics Files to Market Andara(TM) OFS(TM) Therapy for Acute Spinal Cord Injury under Humanitarian Device Exemption
|
|
21 Feb 2007 |
Roche and GSK agree on two transactions
|
|
21 Feb 2007 |
Hybrigenics Focuses its Research on Inhibitors of Ubiquitin-Specific Proteases in Cancer
|
|
21 Feb 2007 |
Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
|
|
21 Feb 2007 |
Genfit Extends Its Drug Discovery Strategic Alliances with Sanofi-Aventis and Solvay
|
|
20 Feb 2007 |
Entelos and Organon Extend Research Agreement
|
|
17 Feb 2007 |
OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in Fracture Repair
|
|
17 Feb 2007 |
InSite Vision Announces License Agreement With Inspire Pharmaceuticals
|
|
17 Feb 2007 |
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
|
|
16 Feb 2007 |
Stem Cell Sciences and Celogos Sign a Licensing Deal on Autogenous Myoblast Transplantation For Urinary Incontinence Therapy
|
|
15 Feb 2007 |
Aastrom's U.S. Clinical Investigator to Report Interim Data on Long Bone Fracture Repair Trial
|
|
15 Feb 2007 |
Acambis signs JE partnership agreement with sanofi pasteur
|
|
15 Feb 2007 |
GW and Otsuka Announce Major Long Term Strategic Cannabinoid Alliance
|
|
15 Feb 2007 |
Halozyme and Baxter Expand Global HYLENEX Collaboration
|
|
15 Feb 2007 |
Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX from the Infuse-Morphine Study
|
|
14 Feb 2007 |
InSite Vision Announces Positive Top-Line Safety Results from Phase 1 AzaSite Plus Clinical Study
|
|
14 Feb 2007 |
Organon and Pharmacopeia Enter Into Discovery, Development and Commercialization Alliance
|
|
14 Feb 2007 |
Elixir Pharmaceuticals and Siena Biotech S.p.A. Enter Agreement to Evaluate SIRT1 Inhibitors in Huntington's Disease
|
|
14 Feb 2007 |
Osiris Announces Top-Line Interim Results for Stem Cell Trial for Knee Repair
|
|
13 Feb 2007 |
AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
|
|
13 Feb 2007 |
Adeza to Be Acquired by Cytyc for $24 Per Share
|
|
13 Feb 2007 |
Medivir Outlicenses The Antiviral Compound MIV-160 To Guangdong Lantai Viewland Pharmaceutical CO. LTD
|
|
10 Feb 2007 |
Q-Med has entered into a development and commercialisation agreement regarding botulinum toxin products
|
|
10 Feb 2007 |
Q-Med has entered into a development and commercialisation agreement regarding botulinum toxin products
|
